https://www.selleckchem.com/pr....oducts/grazoprevir.h
itional neuroprotective agents, with beneficial immunomodulatory effects, require exploration in IS-HI models. Acute infection/inflammation is known to exacerbate perinatal brain injury and can worsen the outcomes in neonatal encephalopathy. Therapeutic HT is the current standard of care for all infants with NE, but the benefit in infants with coinfection/inflammation is unknown. In a piglet model of inflammation (LPS)-sensitized HI, we observed no evidence of neuroprotection with cooling for 24 h, based on our primary outcome measu
Like
Comment
Share
